Susan M. Harrington

7.8k total citations · 1 hit paper
83 papers, 5.2k citations indexed

About

Susan M. Harrington is a scholar working on Infectious Diseases, Oncology and Epidemiology. According to data from OpenAlex, Susan M. Harrington has authored 83 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Infectious Diseases, 27 papers in Oncology and 24 papers in Epidemiology. Recurrent topics in Susan M. Harrington's work include Cancer Immunotherapy and Biomarkers (24 papers), Immunotherapy and Immune Responses (17 papers) and CAR-T cell therapy research (14 papers). Susan M. Harrington is often cited by papers focused on Cancer Immunotherapy and Biomarkers (24 papers), Immunotherapy and Immune Responses (17 papers) and CAR-T cell therapy research (14 papers). Susan M. Harrington collaborates with scholars based in United States, Canada and Greece. Susan M. Harrington's co-authors include Haidong Dong, James P. Nataro, Aaron S. Mansfield, Eugene D. Kwon, Christopher J. Krco, Roxana Dronca, Funda Meric‐Bernstam, Ying Wang, Padmanee Sharma and Michael A. Curran and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Susan M. Harrington

82 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PD-L1 Expression in Triple-Negative Breast Cancer

2014 1.1k citations Elizabeth A. Mittendorf, Anne V. Philips et al. Cancer Immunology Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susan M. Harrington United States	39	2.2k	1.6k	1.3k	944	823	83	5.2k
Jiro Fujita Japan	38	812 0.4×	1.2k 0.7×	914 0.7×	1.9k 2.0×	2.1k 2.6×	489	6.9k
Ih‐Jen Su Taiwan	53	2.2k 1.0×	2.3k 1.4×	1.8k 1.4×	355 0.4×	3.2k 3.8×	187	9.3k
Satoshi Iwata Japan	43	1.0k 0.5×	727 0.5×	632 0.5×	435 0.5×	2.3k 2.7×	306	6.0k
François Spertini Switzerland	44	1.7k 0.8×	577 0.4×	2.4k 1.9×	779 0.8×	676 0.8×	201	6.8k
Shawn Skerrett United States	44	357 0.2×	670 0.4×	2.0k 1.6×	1.1k 1.2×	1.6k 1.9×	95	5.5k
Frédéric Altare France	41	818 0.4×	3.6k 2.2×	4.0k 3.2×	346 0.4×	3.5k 4.3×	85	8.0k
Thomas Lehrnbecher Germany	51	2.9k 1.3×	3.0k 1.9×	1.3k 1.0×	745 0.8×	3.5k 4.2×	264	8.2k
Peter A. Sieling United States	45	763 0.3×	2.2k 1.4×	5.3k 4.2×	268 0.3×	2.5k 3.0×	84	8.9k
Maja Weisser Switzerland	38	978 0.4×	1.3k 0.8×	760 0.6×	394 0.4×	1.5k 1.8×	198	4.6k
Gregory R. Harriman United States	25	542 0.2×	619 0.4×	2.8k 2.2×	165 0.2×	658 0.8×	37	7.3k

Countries citing papers authored by Susan M. Harrington

Since Specialization

Citations

This map shows the geographic impact of Susan M. Harrington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan M. Harrington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan M. Harrington more than expected).

Fields of papers citing papers by Susan M. Harrington

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan M. Harrington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan M. Harrington. The network helps show where Susan M. Harrington may publish in the future.

Co-authorship network of co-authors of Susan M. Harrington

This figure shows the co-authorship network connecting the top 25 collaborators of Susan M. Harrington. A scholar is included among the top collaborators of Susan M. Harrington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan M. Harrington. Susan M. Harrington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barham, Whitney, Xin Liu, Susan M. Harrington, et al.. (2023). A Novel Humanized PD-1/PD-L1 Mouse Model Permits Direct Comparison of Antitumor Immunity Generated by Food and Drug Administration–Approved PD-1 and PD-L1 Inhibitors. ImmunoHorizons. 7(1). 125–139. 6 indexed citations

Gicobi, Joanina K., Susan M. Harrington, Henan Zhang, et al.. (2023). A Novel PD-L1 Antibody Promotes Antitumor Function of Peripheral Cytotoxic Lymphocytes after Radical Nephrectomy in Patients with Renal Cell Carcinoma. The Journal of Immunology. 210(12). 2029–2037. 2 indexed citations

Procop, Gary W., Nabin K. Shrestha, Sherilynn Vogel, et al.. (2020). A Direct Comparison of Enhanced Saliva to Nasopharyngeal Swab for the Detection of SARS-CoV-2 in Symptomatic Patients. Journal of Clinical Microbiology. 58(11). 66 indexed citations

Procop, Gary W., et al.. (2019). Chronic laryngitis caused by Mycobacterium Kansasii in a traveler. The Laryngoscope. 129(11). 2534–2536. 3 indexed citations

Sideras, Kostandinos, Robert A. de Man, Susan M. Harrington, et al.. (2019). Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels. Scientific Reports. 9(1). 10677–10677. 41 indexed citations

Harrington, Susan M., Blake W. Buchan, Christopher D. Doern, et al.. (2015). Multicenter Evaluation of the BD Max Enteric Bacterial Panel PCR Assay for Rapid Detection of Salmonella spp., Shigella spp., Campylobacter spp. (C. jejuni and C. coli), and Shiga Toxin 1 and 2 Genes. Journal of Clinical Microbiology. 53(5). 1639–1647. 66 indexed citations

Park, Sean S., Haidong Dong, Xin Liu, et al.. (2015). PD-1 Restrains Radiotherapy-Induced Abscopal Effect. Cancer Immunology Research. 3(6). 610–619. 303 indexed citations

Gustafson, Michael P., Yi Lin, Jonathan Bleeker, et al.. (2015). Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma. Clinical Cancer Research. 21(18). 4224–4233. 38 indexed citations

Harrington, Susan M., et al.. (2015). Acid-fast Smear and Histopathology Results Provide Guidance for the Appropriate Use of Broad-Range Polymerase Chain Reaction and Sequencing for Mycobacteria. Archives of Pathology & Laboratory Medicine. 139(8). 1020–1023. 15 indexed citations

10.

Mittendorf, Elizabeth A., Anne V. Philips, Funda Meric‐Bernstam, et al.. (2014). PD-L1 Expression in Triple-Negative Breast Cancer. Cancer Immunology Research. 2(4). 361–370. 1065 indexed citations breakdown →

11.

Mansfield, Aaron S., Anja C. Roden, Tobias Peikert, et al.. (2014). B7-H1 Expression in Malignant Pleural Mesothelioma is Associated with Sarcomatoid Histology and Poor Prognosis. Journal of Thoracic Oncology. 9(7). 1036–1040. 164 indexed citations

12.

Liu, Xin, Vesna Pulko, Susan M. Harrington, et al.. (2012). B7-H1 limits the entry of effector CD8⁺T cells to the memory pool by upregulating Bim. OncoImmunology. 1(7). 1061–1073. 37 indexed citations

13.

Montero, Clemente I., Yvonne R. Shea, Peter A. Jones, et al.. (2008). Evaluation of Pyrosequencing® technology for the identification of clinically relevant non-dematiaceous yeasts and related species. European Journal of Clinical Microbiology & Infectious Diseases. 27(9). 821–830. 30 indexed citations

14.

Stergiopoulou, Theodouli, Joseph Meletiadis, Emmanuel Roilides, et al.. (2007). Host-Dependent Patterns of Tissue Injury in Invasive Pulmonary Aspergillosis. American Journal of Clinical Pathology. 127(3). 349–355. 105 indexed citations

15.

Freeman, Alexandra F., et al.. (2006). LINEZOLID-RESISTANT STAPHYLOCOCCUS AUREUS IN TWO PEDIATRIC PATIENTS RECEIVING LOW-DOSE LINEZOLID THERAPY. The Pediatric Infectious Disease Journal. 25(6). 562–564. 40 indexed citations

16.

Sheikh, Jalaluddin, John R. Czeczulin, Susan M. Harrington, et al.. (2002). A novel dispersin protein in enteroaggregative Escherichia coli. Journal of Clinical Investigation. 110(9). 1329–1337. 18 indexed citations

17.

Hendrix, Craig W., Janet Hammond, Sandra M. Swoboda, et al.. (2001). Surveillance Strategies and Impact of Vancomycin-Resistant Enterococcal Colonization and Infection in Critically Ill Patients. Annals of Surgery. 233(2). 259–265. 38 indexed citations

18.

Sterling, Timothy R., Darcy A. Thompson, Anna Madison, et al.. (2000). HIV-related tuberculosis in a transgender network - Baltimore, Maryland, and New York City area, 1998-2000.. MMWR Morbidity and Mortality Weekly Report. 49(15). 317–320. 28 indexed citations

19.

Sterling, Timothy R., Diana S. Pope, William R. Bishai, et al.. (2000). Transmission ofMycobacterium tuberculosisfrom a Cadaver to an Embalmer. New England Journal of Medicine. 342(4). 246–248. 61 indexed citations

20.

Bishai, William R., Neil M.H. Graham, Susan M. Harrington, et al.. (1996). Rifampin-Resistant Tuberculosis in a Patient Receiving Rifabutin Prophylaxis. New England Journal of Medicine. 334(24). 1573–1576. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact